1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry, tax reform issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
TESS ILLOS —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

21st Century Cures Initiative (House Energy and Commerece Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); potential pharmaceutical provisions in House Budget Resolution (H. Con. Res. 27) and Senate Budget Resolution (S. Con. Res. 11); Possible drug provisions in H.R. 2, the Medicare Access and CHIP Reauthorization Act; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; Drug shortages.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2 (114th), H.Con.Res. 27 (114th), S.Con.Res. 11 (114th)

Medicare/Medicaid MMM

Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Independent Payment Advisory Board (IPAB).

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTRAZENECA TREASURY LIMITED United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.